94 related articles for article (PubMed ID: 24801754)
1. Development of new antiatherosclerotic and antithrombotic drugs utilizing F11 receptor (F11R/JAM-A) peptides.
Babinska A; Clement CC; Swiatkowska M; Szymanski J; Shon A; Ehrlich YH; Kornecki E; Salifu MO
Biopolymers; 2014 Jul; 102(4):322-34. PubMed ID: 24801754
[TBL] [Abstract][Full Text] [Related]
2. Two regions of the human platelet F11-receptor (F11R) are critical for platelet aggregation, potentiation and adhesion.
Babinska A; Kedees MH; Athar H; Sobocki T; Sobocka MB; Ahmed T; Ehrlich YH; Hussain MM; Kornecki E
Thromb Haemost; 2002 Apr; 87(4):712-21. PubMed ID: 12008956
[TBL] [Abstract][Full Text] [Related]
3. A peptide antagonist of F11R/JAM-A reduces plaque formation and prolongs survival in an animal model of atherosclerosis.
Babinska A; Clement CC; Przygodzki T; Talar M; Li Y; Braun M; Wzorek J; Swiatkowska M; Ehrlich YH; Kornecki E; Watala C; Salifu MO
Atherosclerosis; 2019 May; 284():92-101. PubMed ID: 30877938
[TBL] [Abstract][Full Text] [Related]
4. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis.
Babinska A; Kedees MH; Athar H; Ahmed T; Batuman O; Ehrlich YH; Hussain MM; Kornecki E
Thromb Haemost; 2002 Nov; 88(5):843-50. PubMed ID: 12428104
[TBL] [Abstract][Full Text] [Related]
5. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques.
Babinska A; Azari BM; Salifu MO; Liu R; Jiang XC; Sobocka MB; Boo D; Al Khoury G; Deitch JS; Marmur JD; Ehrlich YH; Kornecki E
Thromb Haemost; 2007 Feb; 97(2):272-81. PubMed ID: 17264957
[TBL] [Abstract][Full Text] [Related]
6. Expression of a recombinant protein of the platelet F11 receptor (F11R) (JAM-1/JAM-A) in insect cells: F11R is naturally phosphorylated in the extracellular domain.
Kedees MH; Babinska A; Swiatkowska M; Deitch J; Hussain MM; Ehrlich YH; Kornecki E
Platelets; 2005 Mar; 16(2):99-109. PubMed ID: 15823866
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathways of the F11 receptor (F11R; a.k.a. JAM-1, JAM-A) in human platelets: F11R dimerization, phosphorylation and complex formation with the integrin GPIIIa.
Sobocka MB; Sobocki T; Babinska A; Hartwig JH; Li M; Ehrlich YH; Kornecki E
J Recept Signal Transduct Res; 2004 Feb; 24(1-2):85-105. PubMed ID: 15344881
[TBL] [Abstract][Full Text] [Related]
8.
Babinska A; Clement CC; Li Y; Wzorek J; Przygodzki T; Talar M; Braun M; Swiatkowska M; Ehrlich YH; Kornecki E; Watala C; Salifu MO
Data Brief; 2020 Jun; 30():105516. PubMed ID: 32395574
[TBL] [Abstract][Full Text] [Related]
9. Genomic structure, organization and promoter analysis of the human F11R/F11 receptor/junctional adhesion molecule-1/JAM-A.
Sobocki T; Sobocka MB; Babinska A; Ehrlich YH; Banerjee P; Kornecki E
Gene; 2006 Jan; 366(1):128-44. PubMed ID: 16337094
[TBL] [Abstract][Full Text] [Related]
10. F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?
Kamola P; Babinska A; Przygodzki T
Platelets; 2023 Dec; 34(1):2214618. PubMed ID: 37246517
[TBL] [Abstract][Full Text] [Related]
11. Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment.
Bednarek R; Selmi A; Wojkowska D; Karolczak K; Popielarski M; Stasiak M; Salifu MO; Babinska A; Swiatkowska M
Breast Cancer Res Treat; 2020 Jan; 179(2):325-335. PubMed ID: 31650345
[TBL] [Abstract][Full Text] [Related]
12. Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosis.
Azari BM; Marmur JD; Salifu MO; Cavusoglu E; Ehrlich YH; Kornecki E; Babinska A
Atherosclerosis; 2010 Sep; 212(1):197-205. PubMed ID: 20627246
[TBL] [Abstract][Full Text] [Related]
13. Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines.
Azari BM; Marmur JD; Salifu MO; Ehrlich YH; Kornecki E; Babinska A
J Transl Med; 2011 Jun; 9():98. PubMed ID: 21703019
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation.
Sobocka MB; Sobocki T; Banerjee P; Weiss C; Rushbrook JI; Norin AJ; Hartwig J; Salifu MO; Markell MS; Babinska A; Ehrlich YH; Kornecki E
Blood; 2000 Apr; 95(8):2600-9. PubMed ID: 10753840
[TBL] [Abstract][Full Text] [Related]
15. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis.
Cavusoglu E; Kornecki E; Sobocka MB; Babinska A; Ehrlich YH; Chopra V; Yanamadala S; Ruwende C; Salifu MO; Clark LT; Eng C; Pinsky DJ; Marmur JD
J Am Coll Cardiol; 2007 Oct; 50(18):1768-76. PubMed ID: 17964041
[TBL] [Abstract][Full Text] [Related]
16. The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.
Czubak-Prowizor K; Babinska A; Swiatkowska M
Mol Cell Biochem; 2022 Jan; 477(1):79-98. PubMed ID: 34533648
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension.
Ong KL; Leung RY; Babinska A; Salifu MO; Ehrlich YH; Kornecki E; Wong LY; Tso AW; Cherny SS; Sham PC; Lam TH; Lam KS; Cheung BM
Am J Hypertens; 2009 May; 22(5):500-5. PubMed ID: 19214165
[TBL] [Abstract][Full Text] [Related]
18. Platelet agonist F11 receptor is a member of the immunoglobulin superfamily and identical with junctional adhesion molecule (JAM): regulation of expression in human endothelial cells and macrophages.
Gupta SK; Pillarisetti K; Ohlstein EH
IUBMB Life; 2000 Jul; 50(1):51-6. PubMed ID: 11087121
[TBL] [Abstract][Full Text] [Related]
19. Aging-induced impaired endothelial wall shear stress mechanosensing causes arterial remodeling via JAM-A/F11R shedding by ADAM17.
Tian Y; Fopiano KA; Buncha V; Lang L; Rudic RD; Filosa JA; Dou H; Bagi Z
Geroscience; 2022 Feb; 44(1):349-369. PubMed ID: 34718985
[TBL] [Abstract][Full Text] [Related]
20. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
